Indian media criticizes Pfizer after Ivermectin success

FILE - This October 2021, photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. (Pfizer via AP, File)

FILE – This October 2021, photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. (Pfizer via AP, File)

OAN Newsroom
UPDATED 8:42 AM PT – Tuesday, November 2, 2021

A media company in India are ramping up criticism of COIVD-19 vaccine suppliers following the nation’s success at treating the virus with Ivermectin. In a recent report, Indian television channel WION claimed Pfizer is maximizing revenues by selling COVID-19 vaccines to developing nations on often predatory terms.

“What happens when vaccine manufacturers starts bullying? Governments are silenced, supplies are hoarded and profits take precedence over saving lives.”

— Palki Sharma, foreign affairs reporter – WION

The channel cited a separate report by Public Citizen that detailed Pfizer’s distribution agreements in emerging markets. WION found those contracts give up power to some government authority to Pfizer.

“Practically anything that a sovereign government owns — foreign bank accounts, foreign investments, commercial property, state-run airlines, even oil companies — Pfizer can takeover any or all of these from a government. Basically everything happens in Pfizer terms once a country decides to buy its vaccine.”

— Palki Sharma, foreign affairs reporter – WION

WION’s report went on to describe Pfizer’s actions as having long-term political, economic and social risks to developing countries.

FULL REPORT:

MORE NEWS: White House Acquiring 28M Child Vaccine Doses